Showing results (221-230 of 251) with videos related to
Sort By:
Pageof 26
Advances in Radiation Oncology|February 27, 2023
Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and ChemotherapyKosei Doshita, Yuya Tabuchi, Hirotsugu Kenmotsu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2025
Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small Cell Lung Cancer Harboring EGFR MutationShintaro Kanda, Seiji Niho, Takayasu Kurata, et al.Cancer|February 2, 2016
Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trialMasayuki Takeda, Takeharu Yamanaka, Takashi Seto, et al.Cancer Medicine|July 18, 2022
Clinical impact of tumour burden on the efficacy of PD-1/PD-L1 inhibitors plus chemotherapy in non-small-cell lung cancerTaichi Miyawaki, Hirotsugu Kenmotsu, Kosei Doshita, et al.Investigational New Drugs|July 14, 2021
Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasisTaichi Miyawaki, Hirotsugu Kenmotsu, Michitoshi Yabe, et al.Thoracic Cancer|April 25, 2026
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR MutationsYuko Iida, Hirotsugu Kenmotsu, Keita Mori, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumorsKyoichi Kaira, Masahiro Endo, Masato Abe, et al.Journal for Immunotherapy of Cancer|February 2, 2022
Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study)Takashi Seto, Kaname Nosaki, Mototsugu Shimokawa, et al.Cancer Science|November 30, 2019
Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double-positive lung cancerShinji Takeuchi, Tetsunari Hase, Shinobu Shimizu, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2021
Clinical impact of walking capacity on the risk of disability and hospitalizations among elderly patients with advanced lung cancerTaro Okayama, Tateaki Naito, Yusuke Yonenaga, et al.Pageof 26